SCHEMBL457923

SCHEMBL457923

COc1cc(OC)c(-c2c(OC)cc(OC)cc2P(c2cc(C)c(OC)c(C)c2)c2cc(C)c(OC)c(C)c2)c(P(c2cc(C)c(OC)c(C)c2)c2cc(C)c(OC)c(C)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 2/20 0.38
NQO2 P16083 2/20 0.36
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
ELANE P08246 1/20 0.34
ACHE P22303 2/20 0.33
CYP19A1 P11511 1/20 0.33
LMNA P02545 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
USP2 O75604 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29536408 1.00 CYP1A2 (0.38) CYP1A2ALDH1A1CYP3A4NQO2CYP1A1
SCHEMBL15121089 0.92 CA12 (0.34) CYP1A2ALDH1A1CYP3A4NQO2CYP1A1
SCHEMBL459816 0.85 ALDH1A1 (0.31) CYP1A2ALDH1A1CYP3A4NQO2
SCHEMBL458412 0.85 ALDH1A1 (0.41) CYP1A2ALDH1A1CYP3A4NQO2CYP1A1
SCHEMBL30018007 0.85 ALDH1A1 (0.41) CYP1A2ALDH1A1CYP3A4NQO2CYP1A1
SCHEMBL30017862 0.85 ALDH1A1 (0.41) CYP1A2ALDH1A1CYP3A4NQO2CYP1A1
SCHEMBL457822 0.80 CA1 (0.38) CYP1A2ALDH1A1CYP3A4CYP1A1CYP1B1
SCHEMBL29536225 0.80 CA1 (0.38) CYP1A2ALDH1A1CYP3A4CYP1A1CYP1B1
SCHEMBL458029 0.79 ACHE (0.41) CYP1A2ALDH1A1CYP3A4NQO2CYP1A1
SCHEMBL10073368 0.78 CA12 (0.44) CYP1A2ALDH1A1CYP3A4CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9062085-B2 Biaryl diphosphine ligands, intermediates of the same and their use in asymmetric catalysis KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2015-06-23 US disclosed
US-9062085-B2 Biaryl diphosphine ligands, intermediates of the same and their use in asymmetric catalysis KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2015-06-23 US disclosed
US-20130184479-A1 BIARYL DIPHOSPHINE LIGANDS, INTERMEDIATES OF THE SAME AND THEIR USE IN ASYMMETRIC CATALYSIS KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2013-07-18 US disclosed
US-20130184479-A1 BIARYL DIPHOSPHINE LIGANDS, INTERMEDIATES OF THE SAME AND THEIR USE IN ASYMMETRIC CATALYSIS KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2013-07-18 US disclosed
EP-2614069-A1 BIARYL DIPHOSPHINE LIGANDS, INTERMEDIATES OF THE SAME AND THEIR USE IN ASYMMETRIC CATALYSIS Kanata Chemical Technologies Inc. (CA) 2013-07-17 EP disclosed
WO-2012031358-A1 BIARYL DIPHOSPHINE LIGANDS, INTERMEDIATES OF THE SAME AND THEIR USE IN ASYMMETRIC CATALYSIS KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130184479-A1 BIARYL DIPHOSPHINE LIGANDS, INTERMEDIATES OF THE SAME AND THEIR USE IN ASYMMETRIC CATALYSIS AGPS, COASY, BLVRB CYP1A2 57/4885ALDH1A1 1187/4885CYP3A4 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.